Literature DB >> 19834761

Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.

Nand Lal Sharma1, Vikram K Mahajan, Nitin Ranjan, Vikas Chander Sharma, Mudita Gupta.   

Abstract

Systemic sclerosis sine scleroderma is a rare form of limited cutaneous scleroderma. These patients manifest without cutaneous involvement, but do not differ in its clinical or laboratory features and prognosis from classical systemic sclerosis. In the absence of cutaneous signs/symptoms, its diagnosis is delayed leading to morbidity. The exact prevalence of dystrophic calcification in systemic sclerosis sine scleroderma, though a feature of systemic sclerosis, is not known. Development of dystrophic calcification further aggravates patient's woes. This paper describes systemic sclerosis sine scleroderma in a 17-year-old girl diagnosed initially as seronegative juvenile rheumatoid arthritis. She developed progressively increasing disk-like masses of calcinosis over the gluteal regions, knee, elbow, and ankle joints fixed to the overlying skin associated with malaise, anorexia, and weight loss. There was no Raynaud's phenomenon, dysphagia, dyspnoea, sclerodermatous skin, sclerodactyly, telangectasias, or muscle tenderness/weakness. Digital pitted scars, elevated anticentromere antibody values, esophageal hypomotility, and fluffy calcification in subdermal soft tissues in gluteal regions and around wrist, hip, knees, heels, and ankle joints (without affecting the underlying structures) were detected. Therapy with diltiazem and magnesium/aluminum antacids was useful in resolving calcinosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834761     DOI: 10.1007/s10067-009-1303-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

Review 1.  Expanding role of bisphosphonate therapy in children.

Authors:  L R Shoemaker
Journal:  J Pediatr       Date:  1999-03       Impact factor: 4.406

2.  Soft tissue calcification treated with local and oral magnesium therapy.

Authors:  L Steidl; R Ditmar
Journal:  Magnes Res       Date:  1990-06       Impact factor: 1.115

Review 3.  Clinical manifestations of systemic sclerosis.

Authors:  V D Steen
Journal:  Semin Cutan Med Surg       Date:  1998-03

4.  Ultrastructural study of calcinosis universalis with dermatomyositis.

Authors:  T Kawakami; C Nakamura; H Hasegawa; S Eda; S Akahane; T Yamazaki; N Takasu
Journal:  J Cutan Pathol       Date:  1986-04       Impact factor: 1.587

5.  Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.

Authors:  H Poormoghim; M Lucas; N Fertig; T A Medsger
Journal:  Arthritis Rheum       Date:  2000-02

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Scleroderma renal crisis as a presenting feature in the absence of skin involvement.

Authors:  U Zwettler; K Andrassy; R Waldherr; E Ritz
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

8.  Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment.

Authors:  T Nakagawa; T Takaiwa
Journal:  J Dermatol       Date:  1993-09       Impact factor: 4.005

Review 9.  Low dose warfarin treatment for calcinosis in patients with systemic sclerosis.

Authors:  T Cukierman; E Elinav; M Korem; T Chajek-Shaul
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

10.  Treatment of calcinosis with diltiazem.

Authors:  G M Palmieri; J I Sebes; J A Aelion; M Moinuddin; M W Ray; G C Wood; M R Leventhal
Journal:  Arthritis Rheum       Date:  1995-11
View more
  2 in total

Review 1.  Update on systemic sclerosis.

Authors:  Courtney J McCray; Maureen D Mayes
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

2.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.